Amyloid-binding Small Molecules Efficiently Block SEVI (Semen-derived Enhancer of Virus Infection)- and Semen-mediated Enhancement of HIV-1 Infection

Postcoital Bioavailability and Antiviral Activity of 0.5% PRO 2000 Gel: Implications for Future Microbicide Clinical Trials

(2010) Marla J. Keller et al.   PLoS One

Increased CCL2 Expression and Macrophage/Monocyte Migration During Microbicide-Induced Vaginal Irritation

(2009) Carsten Alt et al.   CURRENT HIV RESEARCH

Aminoquinoline Surfen Inhibits the Action of SEVI (Semen-derived Enhancer of Viral Infection)

(2009) Nadia R. Roan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Human Immunodeficiency Virus Type 1 Is Trapped by Acidic but Not by Neutralized Human Cervicovaginal Mucus

(2009) S. K. Lai et al.   JOURNAL OF VIROLOGY

Glycerol monolaurate prevents mucosal SIV transmission

(2009) Qingsheng Li et al.   NATURE

ORIGINAL ARTICLE: Quantification and Comparison of Toll-Like Receptor Expression and Responsiveness in Primary and Immortalized Human Female Lower Genital Tract Epithelia

(2008) Melissa M. Herbst-Kralovetz et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Assay To Screen for Molecules That Associate with Alzheimer's Related β-Amyloid Fibrils

(2008) Petra Inbar et al.   ANALYTICAL CHEMISTRY

Mycoplasma genitalium-Encoded MG309 Activates NF- B via Toll-Like Receptors 2 and 6 To Elicit Proinflammatory Cytokine Secretion from Human Genital Epithelial Cells

(2008) C. L. McGowin et al.   INFECTION AND IMMUNITY

The Cationic Properties of SEVI Underlie Its Ability To Enhance Human Immunodeficiency Virus Infection

(2008) N. R. Roan et al.   JOURNAL OF VIROLOGY

Vaginal microbicides and the prevention of HIV transmission

(2008) Blayne Cutler et al.   LANCET INFECTIOUS DISEASES